Search
Adolescents and young adults (AYA)
Spotlight on AYAAdolescents and young adults (AYA) with hematologic diseases are a unique group with special characteristics and needs. In recent years, the challenges related to the management of AYA (particularly in relation to cancer) have increasingly been recognized.
Read moreAdvocacy priorities
The European Union works on countless pieces of legislation and policies that affect the health ecosystem. Some are relevant to most medical disciplines, including hematology—such as the legislation on health data or pharmaceuticals.
Read moreEU funding calls for hematology
Horizon Europe
MSCA Feedback to Policy 2024 (deadline: September 4, 2024)
MSCA International Cooperation 2024 (deadline: September 4, 2024)
MSCA Postdoctoral Fellowship 2024 (deadline: September 11, 2024)
Improving the understanding and management of late-effects in adolescents and young adults (AYA) with cancer (deadline: September…
Selected EMA news
September 2024Safety update
Withdrawal of Oxbryta (Voxelotor) – marketing authorisation suspended
Treatment of haemolytic anaemia (excessive breakdown of red blood cells) due to sickle cell disease
New medicines approved
Adzynma (rADAMTS13) - orphan medicine
Treatment of congenital thrombotic thrombocytopenic purpura (an inherited clotting disorder)
Other…
Burnout survey
The burnout survey is open until 23:59 on October 11, 2024. Complete the survey now
Burnout in hematologyBurnout is, in broad terms, a state of physical, mental, and emotional exhaustion.